PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 8, 2026Asian Spine Journal0 citationsOpen Access

Opioid-sparing effect of postoperative continuous intravenous nefopam in multilevel degenerative lumbar spinal fusion: a randomized double-blind placebo-controlled trial

BSBorriwat SantipasPLPanya LuksanapruksaSTSuwimon Tangwiwat

Key Points

  • This research aims to evaluate the efficacy of continuous intravenous nefopam in reducing opioid requirements post-surgery.
  • Randomized double-blind placebo-controlled trial designed for spinal fusion patients
  • Administration of continuous intravenous nefopam or placebo after surgery
  • Evaluation of postoperative opioid consumption and adverse events
  • Nefopam significantly reduced opioid requirements after surgery
  • No increase in adverse events associated with nefopam infusion

Abstract

In patients undergoing multilevel degenerative lumbar spinal fusion, continuous intravenous nefopam infusion significantly reduced postoperative opioid requirements without worsening adverse events. Nefopam may be a useful opioid-sparing adjunct in multimodal postoperative pain protocols for major spine surgery.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Santipas et al. (2026) studied this question.

synapsesocial.com/papers/69d5f14b74eaea4b11a7ae0bhttps://doi.org/10.31616/asj.2025.0512
Ask AI
Helpful
Bookmark
Share
View Full Paper